Topoisomerase II as a Novel Antiviral Target against Panarenaviral Diseases
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v15010105
Abstract: Although many arenaviruses cause severe diseases with high fatality rates each year, treatment options are limited to off-label use of ribavirin, and a Food and Drug Administration (FDA)-approved vaccine is not available. To identify novel… read more here.
Keywords: topoisomerase novel; novel antiviral; replication; target panarenaviral ... See more keywords